Replies to post #56 on AMAG Pharmaceuticals (AMAG)

[surf1944]

8:22AM AMAG Pharma: MSMB files revised preliminary consent solicitation statement to replace the Board of Directors of AMAG Pharmaceuticals (AMAG) 13.63 : MSMB Capital Management announced that it has filed an amended preliminary Consent Solicitation Statement with the SEC that seeks, among other things, to remove each of the current directors of AMAG and replace them with MSMB's nominees. MSMB amended its filing to increase the number of nominees to include Richard Brewer and David Gryska, each of whom have extensive management experience in the healthcare industry.